BraTS-Path Challenge: Assessing Heterogeneous Histopathologic Brain Tumor Sub-regions

no code implementations • 17 May 2024 • Spyridon Bakas, Siddhesh P. Thakur, Shahriar Faghani, Mana Moassefi, Ujjwal Baid, Verena Chung, Sarthak Pati, Shubham Innani, Bhakti Baheti, Jake Albrecht, Alexandros Karargyris, Hasan Kassem, MacLean P. Nasrallah, Jared T. Ahrendsen, Valeria Barresi, Maria A. Gubbiotti, Giselle Y. López, Calixto-Hope G. Lucas, Michael L. Miller, Lee A. D. Cooper, Jason T. Huse, William R. Bell

Glioblastoma is the most common primary adult brain tumor, with a grim prognosis - median survival of 12-18 months following treatment, and 4 months otherwise.

Benchmarking

Detecting Histologic & Clinical Glioblastoma Patterns of Prognostic Relevance

no code implementations • 1 Feb 2023 • Bhakti Baheti, Sunny Rai, Shubham Innani, Garv Mehdiratta, Sharath Chandra Guntuku, MacLean P. Nasrallah, Spyridon Bakas

Glioblastoma is the most common and aggressive malignant adult tumor of the central nervous system, with a grim prognosis and heterogeneous morphologic and molecular profiles.

Decision Making Management +2